Concepedia

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

BS Andersson, James Gajewski, Michèle L. Donato, Sergio Giralt, Victor G. Gian, John R. Wingard, Stefano Tarantolo, Hugo F. Fernández, WW Hu, Karl G. Blume,

Bone Marrow Transplantation · 2000 · 47 citations · 15 references

DOI

Concepts

References

15

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

PJ Tutschka, EA Copelan, JP Klein · Blood · 1987 · 539 citations · Full text

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

Louise B. Grochow, Richard J. Jones, Robert B. Brundrett et al. · Cancer Chemotherapy and Pharmacology · 1989 · 405 citations

, , +4

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide

Clift Ra, CD Buckner, Thomas Ed et al. · Blood · 1994 · 356 citations · Full text

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

John T. Slattery, R A Clift, CD Buckner et al. · Blood · 1997 · 352 citations

Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.

John T. Slattery, Jean E. Sanders, CD Buckner et al. · PubMed · 1995 · 351 citations